Gingko Bioworks secures $350 mln for Ferment Consortium
Boston-based Ginkgo Bioworks, an organism company, has raised $350 million for the Ferment Consortium, a new fund. Ferment Consortium's investors include Viking Global Investors, General Atlantic and Cascade Investment. Ferment Consortium is focused on backing Ginkgo spinout companies.
10 October 2019•2 mins read
